Author:
Sohl Brianna C.,Hardin Skiey,Jacobs Kristin M.
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. James SE, Herman JL, Rankin S, Keisling M, Mottet, L, Anafi M. The report of the 2015 U.S. transgender survey. Washington, DC: National Center for Transgender Equality; 2016. [Internet]. Available from: https://transequality.org/sites/default/files/docs/usts/USTS-Full-Report-Dec17.pdf.
2. •• Coleman E, Radix AE, Bouman WP, Brown GR, de Vries ALC, Deutsch MB, et al. Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgend Health. 2022;23(1):S1-259. https://doi.org/10.1080/26895269.2022.2100644. This clinical consensus document provided by WPATH includes the most up-to-date and comprehensive guidelines for providing quality and ethical care to TGD individuals.
3. Kinnear HM, Moravek MB. Reproductive capacity after gender-affirming testosterone therapy. Hum Reprod. 2023;31(10):1872–80. https://doi.org/10.1093/humrep/dead158.
4. Barrero JA, Mockus I. Preservation of fertility in transgender men on long-term testosterone therapy: a systematic review of oocyte retrieval outcomes during and after exogenous androgen exposure. Transgend health. 2023;8(5):408–19. https://doi.org/10.1089/trgh.2022.0023.
5. Leung A, Sakkas D, Pang S, Thornton K, Resetkovia N. Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine. Fertil Steril. 2019;112(5):858–65. https://doi.org/10.1016/j.fertnstert.2019.07.014.